The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

mRNA Therapeutics and Vaccines: Key Opinion Leaders

  • Lowest Price Guaranteed From USD 749

  • Published
    September 2021

  • Pages
    116

  • View Count
    313

Example Insights


Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Context 	Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Opinions-of-Experts-in-the-Field Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines- Key-Developers-in-This-Field Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Contemporary-Scientific-Expertise
Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Key-Opinion-Leaders 	Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Expertise-and-Impact-of-Contributions Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Analysis-of-KOL-Expertise 	Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-KOL-Competitiveness-Analysis
Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Leading-KOLs-in-North America Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Detailed-Profiles-of-a-Number-of-KOLs Key-Opinion-Leaders-in-mRNA-Therapeutics-and-Vaccines-Regulatory-Information  

Overview

Over the last two decades, medical researchers have been able to achieve proof-of-concept and demonstrate the viability of benefits of mRNA-based interventions. In fact, currently, there are more than 65 mRNA-based therapeutics and over 85 mRNA vaccines under development. In vitro transcribed mRNA is now being evaluated as a treatment option for several oncological and genetic disorders. Moreover, experts believe that the applications of this upcoming product class are potentially limitless. Synthetic mRNA can also be engineered to facilitate the in vitro development of several types of cell and gene therapies. For instance, it can be used to activate key molecular pathways in somatic cells in order to induce pluripotency, an important prerequisite for stem cell therapy. There are studies that describe the use of in vitro transcribed mRNA encoding novel designer nucleases to manipulate genetic material, which is a common practice in the development of advanced therapy medicinal products. Further, the COVID-19 pandemic has enabled medical researchers to realize the vast potential of mRNA-based vaccines. Contrary to traditional vaccinology, the aforementioned type of preventive interventions do not require the use of live (attenuated) pathogens, hence, are significantly less risky. Moreover, mRNA is expressed in the cytoplasm and does not enter cellular nuclei, implying that it is incapable of adversely interacting with the genome of patients. In this context, it is worth mentioning that the mRNA vaccines developed by Pfizer / BioNtech (COMIRNATY® / BNT-162) and Moderna (SpikeVax / mRNA-1273) against the novel coronavirus strain, were, for the first time in the history of vaccine development, developed and approved for use, in under a year. 

Being a biomolecule, mRNA is well tolerated in vivo; however, despite its numerous benefits, there are several challenges that presently limit its use. Although recent advances in controlling translational efficacy and immunogenicity have led to the development of multiple viable pharmacological leads (a few of which are already approved for use), there are still several challenges that need to be addressed. One of the major concerns is related to the inherent instability, which significantly compromises in vivo persistence, of the molecule. In addition, the targeted in vivo delivery of this relatively fragile type of intervention is also complicated. Over the years, attempts to manipulate the chemical structure of mRNA have enabled therapy developers to engineer relative more stable versions of the molecule. Similarly, lipoplexes and lipid-based nanoparticles have been successfully used to administer mRNA-based vaccines. Given that many companies (most of which have fairly limited expertise) are now in pursuit of further improving this technology, and the fact that standards related to the safety and regulation of such interventions are subject to increasing stringency, the need for expert guidance on new molecular entity design and product development is paramount. Contemporary scientific expertise in mRNA, and its numerous applications, is backed by more than 20 years of dedicated research in this field. This primary objective of this report is to identify leading scientists and industry leaders in this domain and assess the impact of their contributions to the field, till date.

Scope of the Report

The “Key Opinion Leaders in mRNA Therapeutics and Vaccines” report features the identities of some of the key opinion leaders in this domain, offering a quantitative approach to assess the relative expertise of thought leaders in this subject, along with the means for aspiring therapy developers to contact such eminent personalities. The information in this report has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint deck, summarizing the ongoing activity in this domain, and key insights drawn from the available data. The report features the following details:

  • Identities of Contemporary KOLs

An in-depth analysis of leading technical experts in the field of mRNA therapeutics and vaccines, featuring a quantitative assessment of all the available details across 30+ parameters related to individual KOLs, including the contact information (email ID, and links to their respective LinkedIn and ResearchGate profile, as well as other details) of those individuals who have publicly disclosed such details

  • Assessment of Technical Expertise and Relative Impact on the Field of mRNA-based Interventions

An analysis of 25+ different (quantifiable) parameters, indicative of the expertise and impact created by different types of KOLs in this domain. The parameters considered in this analysis include inputs from publicly available information that describe experience, technical acumen, scientific activity, impact of contributions, strength of professional network, social media activity, and geographical location of individual KOLs

  • KOL Competitiveness Analysis

A competitive benchmarking and valuation analysis, taking into account all available data on 25+ parameters that highlight the relative strength (technical expertise) and impact created on the industry, by individual KOLs

  • KOL Profiles and Recent Activity Snapshots

Detailed profiles of top-ranking KOLs (according to our proprietary competitiveness analysis), featuring all available details, including (but not limited to) years of experience (both general and specific to mRNA-based research), educational qualifications, previous / current affiliations, previous / current designations, strength of professional networks (LinkedIn and ResearchGate), scientific activity (such as number of publications, and trials conducted), and contact information (as disclosed by individual KOLs in the public domain). In addition, this section includes brief snapshots of some of the recent contributions (such as publications, clinical trials conducted, keynote speeches delivered and posts on social media) of the KOLs captured in the report database, who have been profiled

Deliverable Outlines

Excel Deliverable

  1. The first section of the spreadsheet features details on the scope of the report and the inclusion and exclusion criteria taken into consideration during the data collection phase.
  2. The second section of the deliverable is a summary MS Excel dashboard, offering a detailed graphical perspective of the contemporary KOL landscape, featuring innovation and knowledge leaders, clinical research investigators, technical domain experts and industry leaders. 
  3. The third section of the spreadsheet is an elaborate table, which provides information on the leading technical experts in the field of mRNA therapeutics and vaccines. It features all the available details (across 30+ parameters) related to individual KOLs, for whom the relevant details are available in the public domain. 

PowerPoint Deliverable

  1. The first part of this deliverable features an executive summary of the key insights generated from an in-depth analysis of various KOLs who are engaged in conducting research on mRNA and / or the development of mRNA-based therapeutics and vaccines.
  2. The next section is a broad perspective on the various types of KOLs that have been captured in this report and details related to their experience (past / current) and the various contributions that they have made in the field of mRNA therapeutics and vaccines. 
  3. The third section of the deliverable features an analysis of 17 different (quantifiable) parameters based on which we have developed an informed opinion on the relative strength of an individual KOL in this domain. The aforementioned parameters include inputs from publicly available information that describe the experience, technical acumen, strength of professional network, social media activity and geographical location, of individual KOLs.
  4. In this section of the deliverable, we have quantified and analyzed 10 different parameters to develop an informed opinion on the relative impact that an individual KOL has had in this domain. The aforementioned parameters include inputs from publicly available information that describe the scientific activity and impact of contributions of individual KOLs.
  5. Based on our understanding of the relative strength and impact on industry, an elaborate 2×2 matrix was plotted to assess the competitiveness of individual KOLs. From the matrix, all of the individuals with high strength and impact scores were separately inspected against the contributions that they have made so far, in this domain. Further, a cumulative score (which takes into account both the aforementioned parameters) was assigned to each KOL and compared to a similar numerical value, which reflects the relative expertise of a knowledge leader, from a reliable third-party source.    
  6. Finally, the report features profiles of prominent KOLs who emerged from among the top-ranking individuals (based on relative strength and impact on industry) in our proprietary competitiveness analysis. Each profile features all available details on the various KOLs who have been captured in the report. Further, we have provided snapshots of some of the recent contributions (such as publications, clinical trials conducted, keynote speeches delivered and posts on social media) of the same individuals.

Contents

Table Of Contents

Excel Deliverable 
1. Data Collection Guide

2. Summary Dashboard
2.1. Overview of KOL Landscape
2.2. KOL Competitiveness Analysis
2.3. Interactive KOL Summaries
2.3.1. KOL Strength Parameters
2.3.2. Impact on Industry Parameters
2.3.3. Contact Information

3. KOL Data 

4. Appendix I: Pivot Tables

5. Appendix II: Country / Geography Codes
  
PowerPoint Deliverable  
1. Context  

2. Project Approach & Objectives

3. Executive Summary

4. Contemporary KOL Landscape
4.1. Distribution by Type of KOL
4.2. Geographical Distribution

5. Analysis of KOL Strength
5.1. Overview and Methodology
5.2. Evaluation based on Experience
5.3. Evaluation based on Technical Acumen
5.4. Evaluation based on Professional Network
5.5. Evaluation based on Social Media Activity
5.6. Evaluation based on Geographical Location
5.7. Assessment of Relative KOL Strength

6. Analysis of Impact on Industry
6.1. Overview and Methodology
6.2. Evaluation based on Scientific Activity
6.3. Evaluation based on Impact on Industry
6.4. Assessment of Relative Impact on Industry 

7. KOL Competitiveness Analysis
7.1. Overview and Methodology 
7.2. Analysis of Clinical Researcher Investigators in North America
7.3. Analysis of Clinical Researcher Investigators in Europe
7.4. Analysis of Clinical Researcher Investigators in Asia Pacific
7.5. Analysis of Clinical Researcher Investigators in Rest of the World
7.6. Analysis of Innovation and Knowledge Leaders in North America
7.7. Analysis of Innovation and Knowledge Leaders in Europe
7.8. Analysis of Innovation and Knowledge Leaders in Asia Pacific
7.9. Analysis of Industry Leaders in Rest of the World
7.10. Analysis of Industry Leaders in North America
7.11. Analysis of Industry Leaders in Europe
7.12. Analysis of Industry Leaders in Asia Pacific
7.13. Analysis of Industry Leaders in Rest of the World
7.14. Analysis of Technical Domain Experts in North America
7.15. Analysis of Technical Domain Experts in Europe
7.16. Analysis of Technical Domain Experts in Asia Pacific
7.17. Analysis of Technical Domain Experts in Rest of the World

8. KOL Profiles and Recent Activity Snapshots
8.1. KOL A (North America)
8.2. KOL B (North America)
8.3. KOL C (North America)
8.4. KOL D (North America)
8.5. KOL E (North America)
8.6. KOL F (Europe)
8.7. KOL G (Europe)
8.8. KOL H (Europe)
8.9. KOL I (Europe)
8.10. KOL J (Europe)
8.11. KOL K (Asia Pacific)
8.12. KOL L (Asia Pacific)
8.13. KOL M (Asia Pacific)
8.14. KOL N (Asia Pacific)
8.15. KOL N (Asia Pacific)
8.16. KOL O (Rest of the World)
8.17. KOL P (Rest of the World)
8.18. KOL Q (Rest of the World)
8.19. KOL R (Rest of the World)
8.20. KOL S (Rest of the World)

9. Appendices

List Of Companies

The following is an indicative list of companies and organizations that have been mentioned in the report. A more comprehensive list of 800+ companies / organizations is available on request

  1. A.O. Ospedale Papa Giovanni XXIII
  2. Aarhus University / Aarhus University Hospital
  3. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  4. Accent Therapeutics
  5. Advirna
  6. AIDS Healthcare Foundation CA US
  7. Ain Shams University
  8. Ajmera Transplant Centre UHN
  9. Albert Einstein College of Medicine
  10. Aldevron
  11. Allele Biotechnology
  12. Alnylam Pharmaceuticals
  13. Alnylam Pharmaceuticals
  14. AmpTech
  15. AMS Bio
  16. Anima Biotech
  17. ApeXBio
  18. Arcturus Therapeutics
  19. Arizona State University
  20. Arrakis Therapeutics
  21. ART Biosciences
  22. Asaf Harofeh Medical Center
  23. AskBio
  24. Assistance Publique - Hôpitaux de Paris
  25. Association Institut de Myologie
  26. Astrazeneca
  27. Atalanta Therapeutics
  28. Atlanta Therapeutics
  29. Auckland Clinical Studies (ACS)
  30. AvantiBio
  31. Avidity Biosciences
  32. Azienda Ospedaliero-Universitaria di Modena
  33. Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia
  34. Aztrazeneca
  35. Balgrist University Hospital
  36. Barbara Ann Karmanos Cancer Institute
  37. Barnsley Hospital NHS Foundation Trust UK
  38. Barts Health NHS Trust
  39. Beijing Friendship Hospital
  40. Beijing Institute of Technology
  41. Ben-Gurion University of the Negev
  42. Bharat Biotech
  43. Bharat Biotech International
  44. Biocad
  45. Biological Mimetics
  46. Biomay
  47. Bioneer
  48. BioNTech
  49. Biosynthesis
  50. Boehringer Ingelheim
  51. Boston Medical Centre
  52. Boston Scientific
  53. Boston University
  54. Boston University School of Medicine
  55. Boston's Children Hospital, Harvard Medical School
  56. California Institute Of technology
  57. Cancer Hospital, Chinese Academy of Medical Science
  58. Cancer Institute and Hospital Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital
  59. Cancer Research UK Cambridge Institute (CRUCI)
  60. Cancer Science Institute, Singapore
  61. Cardiff University
  62. Carnegie Melon University
  63. Case Western Reserve University
  64. Case Western Reserve University
  65. CEA Paris
  66. Cellema
  67. Center for Clinical and Cosmetic Research
  68. Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine Mahidol University
  69. Central VetPharma Consultancy
  70. Centre For Genomic Regulation (CRG)
  71. Centre for Nutrition Research, University of Navarra
  72. Centre for Research in Agricultural Genomics (CRAG)
  73. Centre Henri Becquerel
  74. Centre Hospitalier De La Région D'Annecy
  75. Centre Hospitalier le Vinatier & CNRS UMR 5229 (BRON, France)
  76. Centre Hospitalier Lyon Sud, Lyon, France
  77. Centre Hospitalier Universitaire de Liège
  78. Centre Hospitalier Universitaire le Dantec (CHUD), Dakar, Senegal
  79. Centro Nacional de Investigaciones Oncológicas
  80. Changhai Hospital
  81. Charles University, Czech Republic
  82. Chicago Medical School, Rosalind Franklin University of Medicine and Science
  83. Children's Hospital of Philadelphia
  84. Children's Hospital, Helsinki University Hospital and the University of Helsinki
  85. Chimeron Bio
  86. China Medical University Hospital
  87. Chinese PLA General Hospital Beijing China
  88. Christchurch Clinical Studies Trust
  89. CHRU de Strasbourg
  90. CHU de Martinique
  91. CHU de Poitiers
  92. CHU SAINT-ETIENNE
  93. Chulalongkorn University
  94. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain
  95. CIBERES SEPAR
  96. City of Hope Medical Center
  97. City of Hope Medical Centre
  98. Click Biosystems
  99. Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Diseases (Medical Clinic II)
  100. Clinique Générale Beaulieu - Swiss International Prostate Center
  101. Coalition for Epidemic Preparedness Innovations (CEPI)
  102. Coca-Cola European Partners
  103. COG Phase I Consortium, Seattle Children's Hospital
  104. Cold Spring Harbor Lab
  105. Copehagen University Hospital Bispebjerg, Copenhagen
  106. Corpometria Institute
  107. Council for Scientific and Industrial Research, South Africa
  108. Creative Biolabs
  109. CureVac
  110. Daiichi Sankyo
  111. Dalhousie University
  112. Dana Farber Cancer Institute
  113. Danish Multiple Sclerosis Research Center
  114. Department of Internal Medicine, Asthma and Alergology, Barlicki Hospital, University Of Lodz
  115. Department of Surgery, National Taiwan University Hospital
  116. Diabetes Unit E. Wolfson Hospital
  117. Duke University
  118. Edith Wolfson Medical Center, Holon
  119. ElevateBio
  120. Eli Lilly
  121. Emory University
  122. Emory University
  123. Epidemiology Service, Local Health Authority of Reggio Emilia, Italy
  124. Essentia Health St. Joe's Medical Center
  125. ETH Zurich
  126. etheRNA
  127. Eurogentec
  128. European Molecular Biology Laboratory
  129. Expansion Therapeutics
  130. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  131. Formulate Bioscience
  132. Fred Hutchinson Cancer Research Center, University of Washington
  133. French Institute of Health and Medical Research
  134. French National Institute for Agriculture, Food, and Environment (INRAE)
  135. Friedrich Miescher Institute for Biomedical Research
  136. Fujita Health University Hospital
  137. Fundacion Infant, Argentina.
  138. Garvan Research Institute
  139. Gene Frontier Corporation
  140. Gennova
  141. Genome Institute Singapore
  142. Genomics, England
  143. George Washington University
  144. German Centre For Neurodegenrative Diseases (DZNE)
  145. Ghent University
  146. GlaxoSmithKilne
  147. Greater Paris University Hospitals - AP-HP
  148. GreenLight Biosciences
  149. Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
  150. GSK Vaccines
  151. H. Lee Moffitt Cancer Center and Research Institute
  152. Hanmi Pharmaceutical
  153. Harvard Medical School
  154. Harvard University
  155. HDT Bio
  156. Hebei Medical University Third Hospital
  157. Hebrew University of Jerusalem
  158. Herlev and Gentofte Hospital, The Department of Orthopedics
  159. Hope Research Center
  160. Hôpital Européen Marseille
  161. Hôpitaux Universitaires de Strasbourg
  162. Hospices Civils de Lyon
  163. Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon)
  164. Hospital Gregorio Marañon
  165. Hospital Korneuburg
  166. Hospital Sant Joan de Deu
  167. Hospital Universitari Vall d'Hebron
  168. Hospitales Universitarios Virgen del Rocío
  169. Howard Hughes Medical Institute
  170. Howard Hughes Medical Institute, Brandeis University
  171. Huazhong University of Science and Technology
  172. IBM Research
  173. Icahn School of Medicine at Mount Sinai
  174. Icahn School of Medicine at Mount Sinai
  175. ICON Early Phase Services
  176. Imperial College London
  177. Indonesia University
  178. Inland Norway University of Applied Sciences
  179. Innovation Forum
  180. Inovio Pharmaceuticals
  181. INSIGHT Copenhagen International Coordinating Centre, Rigshospitalet, University of Copenhagen
  182. Institució Catalana de Recerca i Estudis Avançats (ICREA)
  183. Institute Jacques Monod
  184. Institute of Molecular Biology, Academia Sinica
  185. Institute of Molecular Biotechnology, Vienna, Austria (IBMA)
  186. Institute of Molecular Medicine, Lisbon, Portugal
  187. Institute of Oncology Dr. Rosell (IOR)
  188. Institute of Sports Medicine, Copenhagen
  189. Instituto de Investigación Biomédica de Málaga (IBIMA)
  190. Instituto Mexicano del Seguro Social
  191. Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
  192. Instituto Nacional de Rehabilitación
  193. Instotut Curie
  194. Intellia Therapeutics
  195. International Vaccine Institute
  196. Ionis Pharmaceuticals
  197. IQVIA
  198. IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T)
  199. IRCCS Ospedale San Raffaele
  200. IVIRMA MADRID
  201. Janssen
  202. John Innes Centre
  203. Johns Hopkins Bloomberg School of Public Health
  204. Johns Hopkins University
  205. Joslin Diabetes Center
  206. Karolinska Institutet
  207. Karolinska Institutet Sweden
  208. Karolinska University Hospital Sweden
  209. Karolinska University Hospital, ME Infectious Diseases
  210. Kernal Biologics
  211. Kite Pharma
  212. KU Leuven
  213. KWF Kankerbestrijding
  214. Laboratoire Drouot
  215. Lake Pharma
  216. Landesklinikum Korneuburg, Vienna
  217. Laval University
  218. Leiden University Medical Center
  219. Lemonex
  220. Lemonex
  221. LifeEDIT
  222. Los Alamos National Laboratory
  223. Lucille P. Markey Cancer Center at University of Kentucky
  224. Lund University Hospital Swedwn
  225. M.D. Anderson Cancer Center
  226. Maastricht University
  227. Maastricht University Medical Center (MUMC+)
  228. Maastricht University Medical Centre
  229. Manchester Royal Infirmary
  230. Mansoura University
  231. Massachusetts General Hospital
  232. Matrivax Corporation
  233. Mayo Clinic
  234. McGill University
  235. McMaster University
  236. McMaster University, Department of Medicine, Division of Gastroenterology
  237. MEDES-IMPS
  238. Medical centrum Leeuwarden, Department of pulmonology
  239. Medical College of Wisconsin
  240. Medical University of South Carolina
  241. Medical University of Vienna
  242. Medisch Centrum Leeuwarden
  243. Memorial Sloan-Kettering Cancer Center
  244. Merck
  245. Mercurna
  246. Miescher Pharma
  247. MiNA Therapeutics
  248. Mischer Pharma
  249. Moderna Therapeutics
  250. Moffitt Cancer Center, USA
  251. Monash University
  252. Montreal Heart Institute
  253. MPI Brain Research, Germany
  254. MPI Germany
  255. MRC Laboratory of Molecular Biology
  256. Murdoch Children's Research Institute
  257. National and Kapodistrian University of Athens
  258. National Cancer Institute
  259. National Cardiovascular Center Harapan Kita Hospital Indonesia
  260. National Center of Neurology and Psychiatry, Japan
  261. National Institute of Rehabilitation, Mexico
  262. National Institute on Aging (NIA)
  263. National Institutes of Health
  264. National Kapodistrian University of Athens, Medical School
  265. National University Hospital, Singapore
  266. Necker University Hospital
  267. New York Langone Medical Center
  268. New York University Grossman School of Medicine, The Royal Melbourne Hospital
  269. Newcastle University
  270. n-Lorem
  271. North Texas Veterans Healthcare System Dallas VA Medical Center, University of Texas Southwestern
  272. NorthShore University HealthSystem, Greenville Health System
  273. Northwestern University
  274. Norwegian School of Sport Sciences
  275. Norwegian University of Science and Technology
  276. Novartis Vaccines
  277. Noxxon Pharma
  278. Nymirum
  279. Odense University Hospital
  280. Ohio State University
  281. Ohio State University Comprehensive Cancer Center
  282. OHSU Knight Cancer Institute
  283. Oncotherapeutics
  284. Oslo and Akershus university College
  285. Oslo Metropolitan University
  286. Oslo University Hospital
  287. OZ Biosciences
  288. Padjadjaran University
  289. Pantherna Therapeutics
  290. Penn State College of Medicine
  291. Penn State University
  292. Pennington Biomedical Research Center
  293. Pfizer
  294. phaRNA
  295. ProQR Therapeutics
  296. Protagonist Therapeutics
  297. Providence Therapeutics
  298. PT. Dankos Farma
  299. PTC Therapeutics
  300. Purdue University
  301. Quotient Clinical UK
  302. Rabin Medical Center
  303. Radboud University
  304. RD Biotech
  305. Recode Therapeutics
  306. Regeneron
  307. Reinier de Graaf Groep Netherlands
  308. Rejuvenation Technologies
  309. REXCELERATE
  310. RiboPro
  311. Rigshospitalet
  312. Rigshospitalet Denmark
  313. Rigshospitalet, Denmark
  314. RNACure
  315. RNAimmune
  316. Robert Wood Johnson Medical School/ Rutgers RWJMS Gout Center
  317. Rosalind Franklin University of Medicine and Science
  318. Roswell Park Cancer Institute
  319. Royal Papworth NHS Foundation Trust
  320. Royan Institute
  321. Ruijin Hospital Shanghai Jiao Tong University School of Medicine,
  322. Rutgers Cancer Institute of New Jersey
  323. Rutgers University, USA
  324. Rutgers, The State University of New Jersey
  325. San Gerardo Hospital
  326. San Raffaele Hospital, Italy
  327. Sanofi Pasteur Biologics
  328. Sarah Cannon Research Institute United Kingdom
  329. Scripps Research
  330. SEAMEO Regional Centre for Food and Nutrition
  331. Second Hospital of Shanxi Medical University
  332. Second Military Medical University, Shanghai
  333. Seoul National University
  334. Seoulin Biosciences
  335. Service des Maladies Infectieuses - Hôpital de la Croix Rousse - Hospices Civils de Lyon
  336. Shanghai BDgene
  337. Shanghai Changzheng Hospital
  338. Shanghai Jiao Tong University
  339. Shanghai Jiao Tong University School of Medicine
  340. Shengjing Hospital
  341. Sidney Kimmel Cancer Center at Thomas Jefferson University
  342. Singapore General Hospital
  343. SingHealth Investigational Medicine Unit (IMU)
  344. Siranomics
  345. South African Tuberculosis Vaccine Initiative University of Cape Town
  346. Spark therapeutics
  347. St. Jude Children's Research Hospital
  348. St. Vincent's Institute, Australia
  349. Stanford Cancer Institute
  350. Stanford University
  351. State University of New York at Buffalo
  352. Stemirna Therapeutics
  353. Steno Diabetes Center Copenhagen
  354. Stoke Therapeutics
  355. Storm Therapeutics
  356. Strand Therapeutics
  357. Surgical Department, Hospital of Southern Jutland, Denmark
  358. Synbio Technologies
  359. Tabriz University of Medical Sciences
  360. Taylor's University
  361. Technische Universität München
  362. Tehran University of Medical Sciences
  363. Tel Aviv University
  364. Temple University, Lewis Katz School of Medicine
  365. Texas Tech University Health Sciences Center
  366. Thai Red Cross
  367. the First-Affiliated Hospital of Sun Yat-Sen University
  368. The Francis Crick Institute
  369. The Hebrew University Jerusalem
  370. The Institute of Cancer Research/The Royal Marsden NHSFT
  371. The Newcastle Hospitals NHS Foundation Trust
  372. The Pirbright Institute
  373. The RNA Medicines Company
  374. The Rockefeller university
  375. The Scripps Research Institute, USA
  376. The First Affiliated Hospital of Sun Yat-Sen University
  377. The Sixth Affiliated Hospital, Sun Yat-sen University
  378. The Third Affiliated Hospital of Sun Yat-Sen University, 
  379. The University of Hong Kong
  380. The University of Malaysia Medical Centre, Kuala Lumpur, Malaysia
  381. The University of Texas Health Science Center at Houston, Dept. of Medicine
  382. Thomas J. Watson Research Center
  383. Tiba Biotech
  384. Tongji Hospital
  385. Tongji University Affiliated Shanghai Pulmonary Hospital
  386. Translate Bio
  387. Translational Research Institute for Metabolism and Diabetes
  388. Trilink Biotechnologies
  389. Tropical Pesticides Research Institute, Tanzania
  390. Tsinghua University, China
  391. Turn Biotechnologies
  392. UC Davis Cancer Center
  393. UCSF Carol Franc Buck Breast Care Center
  394. Uganda Research Unit
  395. Ultimovacs
  396. Ultragenyx
  397. UNC Chapel Hill
  398. UNC Lineberger Comprehensive Cancer Center
  399. UNC Lineberger Comprehensive Cancer Center
  400. UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina
  401. Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
  402. Universidade Federal da Bahia
  403. Universitair Ziekenhuis Antwerpen
  404. Universitair Ziekenhuis Brussel
  405. Universitair Ziekenhuis Leuven
  406. Universitat Rovira I Virgili
  407. Universitätsspital Basel
  408. University At Albany
  409. University Children's Hospital Basel, UKBB
  410. University College London
  411. University Health Network, Toronto
  412. University Hospital Antwerp
  413. University Hospital Basel Switzerland
  414. University Hospital Brno
  415. University Hospital Brussels
  416. University Hospital Duesseldorf, Dept. for Hematology, Oncology and Clinical Immunology
  417. University Hospital Olomouc
  418. University Hospital, Antwerp
  419. University Hospital, Basel, Switzerland
  420. University Hospital, Clermont-Ferrand
  421. University Hospital, Rouen
  422. University Hospital, Strasbourg
  423. University Hospitals Coventry and Warwickshire NHS Trust
  424. University Hospitals, Case Comprehensive Cancer Center
  425. University Medical Center Groningen
  426. University of Aarhus
  427. University of Alabama at Birmingham
  428. University Of Amsterdam
  429. University of Antwerp, Laboratory of Experimental Hematology
  430. University Of Arizona
  431. University of Arizona, College of Nursing
  432. University of Bath
  433. University of Bern
  434. University Of Birmingham
  435. University of Brighton
  436. University of California
  437. University of California Irvine
  438. University of California Los Angeles
  439. University of California San Diego
  440. University Of California, Berkely
  441. University of California, Los Angeles
  442. University of California, Riverside
  443. University of California, San Diego
  444. University of California, San Francisco
  445. University of California, Santa Cruz
  446. University of Cambridge
  447. University of Campinas
  448. University of Chicago
  449. University Of Coimbra
  450. University of Cologne
  451. University of Colorado
  452. University of Colorado Anschutz Medical Campus
  453. University of Colorado Boulder
  454. University of Colorado, Denver
  455. University of Copenhagen
  456. University Of Doula
  457. University of East Anglia
  458. University of Edinburgh
  459. University of Electronic Science and Technology of China
  460. University of Florida
  461. University of Frankfurt
  462. University of Heidelberg
  463. University of Illinois
  464. University of Iowa
  465. University of Kansas Medical Center
  466. University of Kentucky
  467. University of Leipzig
  468. University Of Lethbridge
  469. University of Liège
  470. University of Limerick
  471. University of Liverpool
  472. University of Maryland
  473. University of Massachusetts Medical School
  474. University of Massachusetts, Worcester
  475. University of Miami
  476. University of Michigan
  477. University of Munich
  478. University of Navarra
  479. University of New Mexico Biochemistry & Molecular Biology
  480. University of North Carolina
  481. University of North Carolina, Chapel Hill
  482. University of Oslo
  483. University Of Oxford, UK
  484. University of Padau
  485. University of Pennsylvania
  486. University of Pennsylvania Institute for Translational Medicine and Therapeutics
  487. University of Pittsburgh
  488. University of Regensberg
  489. University of Rochester Medical Center, USA
  490. University of São Paulo
  491. University of Seville
  492. University of Southern California
  493. University Of Strasbourg
  494. University Of Sydney
  495. University Of Texas
  496. University of Texas Health Science Center at Houston
  497. University Of Texas, Southwestern Medical Centre
  498. University of Texas, Vanderbilt University
  499. University of Thessaly, School of Physical Education & Sport Science
  500. University of Tokyo
  501. University Of Torronto
  502. University of Tromso
  503. University of Tuebingen
  504. University of Utah
  505. University of Warsaw
  506. University of Washington
  507. University of Wisconsin
  508. University of York
  509. Univesitat Dresden
  510. UNSW, Sydney
  511. UPMC Magee Womens Hopspital
  512. Uppsala University
  513. UT Southwestern Medical Center
  514. VA Western New York Healthcare System, Buffalo, NY
  515. Vanderbilt University
  516. Vanderbilt University Medical Center
  517. Vastra Gotaland Region, Sahlgrenska University Hospital, dept. of Endocrinology
  518. Versameb
  519. VGXI
  520. Wageniningen University
  521. Wake Forest University
  522. Wallace H. Coulter Department of Biomedical Engineering.
  523. Walter Reed Army Institute of Research
  524. Walvax Biotechnology
  525. Washington University
  526. Weizmann Institute Of Science
  527. West China Hospital of Sichuan University
  528. Western University of Health Sciences
  529. Wolfson Medical Center
  530. Wright State Physicians Pharmacology Translational Unit
  531. Yale University
  532. Zealand University Hospital
  533. Ziphius Therapeutics

PRICING DETAILS

USD 749

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com